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Objectives This study sought to investigate which factors are associated with failure of thrombus
aspiration (TA) and if this has prognostic implications.
Background The pathophysiological mechanism and clinical beneﬁt of TA during primary percuta-
neous coronary intervention for acute ST-segment elevation myocardial infarction is still in debate.
Methods Between August 2001 and October 2007, TA was attempted in 1,399 patients. Failure of
TA was deﬁned as the inability to reach and/or cross the occlusion with the aspiration catheter for
effective thrombus removal. In addition, we analyzed patients in which no material could be ob-
tained. We examined baseline clinical and angiographic variables related to failure of TA or to the
lack of aspirate. Follow-up on vital status was obtained at 1 year.
Results In 144 (10.3%) patients, the aspiration catheter failed to cross the lesion. After multivariable
adjustment, marked proximal tortuosity (odds ratio [OR]: 2.88, 95% conﬁdence interval [CI]: 1.92 to
4.31, p  0.001), the presence of a calciﬁed lesion (OR: 2.70, 95% CI: 1.77 to 4.13, p  0.001), and a
bifurcation lesion (OR: 1.97, 95% CI: 1.15 to 3.37, p  0.013) were independent predictors of failed
A. Age over 60 years and the circumﬂex as infarct-related artery were associated with the lack of
spirate. Mortality rates at 1 year were 6.2% in patients with failed TA and 6.4% with successful TA
hazard ratio: 0.98, 95% CI: 0.49 to 1.95, p  0.95).
Conclusions The presence of marked proximal tortuosity of the infarct-related artery, a calciﬁed
lesion, and a bifurcation lesion are independent predictors of failure of thrombus aspiration. We
found that unsuccessful TA did not affect 1-year mortality. (J Am Coll Cardiol Intv 2011;4:634–42)
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635Reperfusion therapy by primary percutaneous coronary in-
tervention (PPCI) with stenting has proven the optimal
approach to reduce morbidity and mortality in acute ST-
segment elevation myocardial infarction (STEMI). In
PPCI, the presence of coronary thrombus has been linked to
distal embolization and microvascular obstruction, reflected
by lower post-procedure myocardial blush grade (MBG)
and no-reflow, which is associated with an increased infarct
size and worse outcome (1–3). Various devices designed to
remove thrombus before stenting have been tested in small-
to moderate-sized randomized controlled trials. Meta-analyses
of adjunctive thrombectomy trials have reported an inconsis-
tent effect of the device-based removal of thrombus from the
infarct-related artery on reperfusion surrogate and clinical
endpoints, with a difference between mechanical and
manual devices in favor of manual aspiration (4 – 8).
See page 643
These previous reports on thrombectomy in the setting of
PPCI did not provide information on the factors associated
with failure to remove thrombus with the various manual
thrombus aspiration (TA) devices and potential prognostic
implications. The reported proportion of unsuccessful em-
ployment varies from 4% to 11%, mainly because of the
inability to cross the lesion (9–11). Even though a retro-
spective study described the failure of the X-Sizer (ev3 Inc.,
Plymouth, Minnesota) mechanical thrombectomy device in
24% of cases (12), it is not known which factors are
associated with failure of the currently used TA catheters
and whether this is associated with worse outcomes. We
sought to determine predictive factors as well as the prog-
nostic value of failure of the TA catheter to reach the
infarct-related lesion in PPCI in a large all-comer acute
STEMI population. In addition, we evaluated which factors
were associated with the inability to retrieve material after
successful positioning of the TA catheter.
Methods
Procedures and medication. We analyzed data from acute
TEMI patients who underwent PPCI with TA at the
cademic Medical Center, University of Amsterdam be-
ween August 2001 and October 2007. Patients were
ligible for PPCI when they presented with acute STEMI
2-mm ST-segment elevation in 2 contiguous leads)
ith symptom duration of 12 h. All interventions were
one according to existing practice guidelines for PCI.
aseline clinical, angiographic, and procedural variables
ere collected prospectively in a dedicated database and
ncluded statements on possible failure of deployment of the
A device used. All patients received aspirin 300 mg and
nfractionated heparin 5,000 to 10,000 IU at the start of the srocedure. The use of glycoprotein IIb/IIIa inhibitors was at
he discretion of the operator. Subsequently, patients were
rescribed aspirin 100 mg once daily for life. Clopidogrel
as administered at a loading dose of 300 or 600 mg before
r immediately after the procedure, followed by 75 mg once
aily for 1 month in patients treated with bare-metal stents,
nd 6 months in patients treated with drug-eluting stents.
TA cohort. In our institution, TA has been available for use
s an adjunct to PPCI since August 2001. In these first
ears, TA was not a proven or formally recommended
herapy and its use was at the discretion of the operator. The
tudy cohort consists of all patients for whom a TA device
as used in adjunct to the standard procedure. Device
election was at the discretion of the operator. The devices
sed were the 7-F Rescue catheter (Boston Scientific/
cimed, Inc., Maple Grove, Minnesota), which became avail-
ble in August 2001 and was
ainly used until the end of 2004;
he 6-F Export aspiration catheter
Medtronic Vascular Inc., Santa
osa, California), which became
vailable in August 2004 and cur-
ently is still in use; and the 6-/
-F Proxis embolic protection de-
ice (St. Jude Medical, St. Paul,
innesota), which became avail-
ble in February 2004 and com-
ines aspiration with distal em-
olic protection. During the study
eriod, PPCI was performed via
he femoral artery only, with the
tandard use of 7-F guiding cath-
ters. After 6-F–compatible Ex-
ort catheters became available at
he end of 2006, both 6-F and
-F catheters were used for this
evice. A total of 1,399 patients
ere identified in which a TA
evice was used during PPCI. We classified patients into 2
roups based on the success of the aspiration catheter to reach
nd/or cross through the lesion without pre-dilation (or with
evice-required pre-dilation in case of the Proxis device). We
ompared baseline clinical and angiographic variables of both
atient groups to determine factors associated with unsuccess-
ul crossing of the TA device. In addition, we analyzed all
atients in which the catheter had successfully crossed the
esion, but no thrombotic material could be obtained, and
ompared them with patients in which aspirate was retrieved.
We obtained information on 1-year vital status from the
nstitutional follow-up database of PCI patients. Patients
ere surveyed 1 year after PCI by means of a mailed,
elf-administered questionnaire. Follow-up information was
Abbreviations
and Acronyms
CI  confidence interval
HR  hazard ratio
IQR  interquartile range
MBG  myocardial blush
grade
OR  odds ratio
PCI  percutaneous
coronary intervention
PPCI  primary
percutaneous coronary
intervention
STEMI  ST-segment
elevation myocardial
infarction
TA  thrombus aspiration
TIMI  Thrombolysis In
Myocardial Infarctionynchronized with computerized mortality records from the
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636National Death Index and local authorities, which were
updated until August 2010.
Statistical analysis. Data are presented as mean  SD for
normally distributed, continuous variables, or median (in-
terquartile range [IQR]), and as frequencies (percentages)
for categorical variables. Differences between patient groups
were tested with Student t test or the Mann-Whitney U
tatistic test as appropriate. Categorical variables were com-
ared by chi-square test. All tests were 2-tailed, and a value
f p  0.05 was considered statistically significant. Cumu-
ative event rates of all-cause mortality were estimated by
he Kaplan-Meier method, and the timing of death is
llustrated by Kaplan-Meier plots. Follow-up was censored
t 1 year. The association between clinical and angiographic
ariables and failure to cross the lesion, or to obtain material
n the case of successful passage, were assessed using logistic
egression analysis in both crude models and multivariable-
djusted models for variables that showed a univariable
ssociation with failure of TA (p  0.1). Variables were
ntered en bloc and the results were expressed as odds ratios
ORs) with 95% confidence intervals (CIs). Statistical
nalysis was performed with SPSS software (SPSS, version
8.0 for Windows, SPSS Inc., Chicago, Illinois).
Figure 1. Study Flow Chart
All patients in whom thrombus aspiration (TA) was attempted were identiﬁed.
patients with successful TA were divided by the presence or absence of thromboticesults
Failure of thrombus aspiration. The study flow chart is
displayed in Figure 1. In 144 patients (10.3%) of the 1,399
patients for whom TA was attempted, the TA catheter
failed to cross the lesion. Baseline clinical and angiographic
characteristics are summarized in Table 1. At a mean age of
63  13 years versus 60  13 years, patients in the failed
TA group were older than patients in the successful TA
group (p 0.009). In addition, these patients more often had
multivessel coronary artery disease (40% vs. 27%, p  0.001).
As expected, some differences in the presence of certain
angiographic variables were seen. A calcified lesion was
more often seen in the group in which TA had failed, at
33.3% versus 14.8% in the successful TA group (p 0.001).
Likewise, marked proximal coronary tortuosity was signifi-
cantly more frequent at 67.9% versus 32.1% in the failed TA
group and successful TA group, respectively (p  0.001).
The circumflex artery was more often the infarct-related
artery in patients with failed TA (20.1%) than it was in the
patients with successful TA (10.0%), p  0.002.
None of the clinical variables was predictive of failure of
TA (Table 2). Marked proximal tortuosity of the coronary
artery, the presence of a calcified lesion, and a bifurcation
were divided into 2 groups (successful TA vs. failed TA). Subsequently,They
material. PPCI  primary percutaneous coronary intervention.
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637lesion as infarct-related lesion were independent predictors
of unsuccessful passage of the catheter across the lesion at
ORs of 2.88 for proximal tortuosity (95% CI: 1.92 to 4.31,
p  0.001), 2.70 for the presence of a calcified lesion (95%
CI: 1.77 to 4.13, p  0.001), and 1.97 for a bifurcation
lesion (95% CI: 1.15 to 3.37, p  0.013).
The procedural characteristics are stated in Table 3. Most
patients received a stent (93.0% in both groups, p  1.00),
whereas direct stenting was performed less often after
failure of TA, at 9.0% versus 30.0% (p  0.001). Post-
rocedural TIMI (Thrombolysis In Myocardial Infarc-
ion) flow grade 3 was observed in 13.9% in the failed TA
roup and 9.5% in the successful TA group (p  0.11).
he average peak creatine kinase-myocardial band values
ere comparable in both groups (280 g/l, IQR: 122 to 495
Table 1. Baseline Clinical and Angiographic Characteristics
Failed Aspiration
(n  144)
Successful Aspira
(n  1,255)
Age, yrs 63 13 60 13
Male 98 (68) 919 (73)
Diabetes mellitus 17 (12) 122 (10)
Hypertension 54 (38) 359 (32)
Hypercholesterolemia 34 (24) 260 (21)
History of smoking 91 (63) 771 (61)
Family history of CAD 66 (46) 531 (42)
Previous PCI 10 (7) 83 (7)
Previous CABG 3 (2) 19 (2)
Previous MI 15 (10) 118 (9)
Symptom-to-balloon, h 3.0 (2.3–4.3) 3.0 (2.2–4.5)
Shock 4 (3) 82 (7)
Multivessel disease 58 (40) 341 (27)
Infarct-related artery
LM 0 (0) 4 (0)
LAD 47 (33) 552 (44)
RCA 67 (44) 558 (45)
Cx 29 (20) 125 (10)
SVG 1 (1) 16 (1)
TIMI ﬂow grade 0 or 1 114 (79) 1,063 (85)
Bifurcation lesion 21 (15) 120 (10)
Ostial lesion 9 (6) 84 (7)
Distal major branch 19 (13) 117 (9)
Side branch 11 (8) 51 (4)
Calciﬁed lesion 48 (33) 186 (15)
Proximal tortuosity 91 (68) 462 (40)
45° lesion angle 39 (29) 292 (26)
Lesion length, mm 15.6 5.3 16.4 5.6
ACC/AHA type C lesion 57 (43) 434 (37)
Values are mean SD, n (%), or median (interquartile range).
ACC/AHA American College of Cardiology/American Heart Association; CAD coronary artery
artery; LM left main; MImyocardial infarction; PCI percutaneous coronary intervention; RCAg/l, vs. 263 g/l, IQR: 127 to 445 g/l; p  0.32). Notehat these values were available only in patients who were
ot transferred to the referring hospitals immediately after
PCI (81 patients with failed TA and 818 patients with
uccessful TA).
Absence of thrombotic aspirate. In 283 (27.3%) of 1,255
patients in whom the aspiration catheter successfully crossed
the lesion, no material could be retrieved. The baseline clinical
and angiographic characteristics are stated in Table 1. These
patients were slightly older at 61  12 years versus 60  13
years for the patients in which thrombotic material could be
obtained (p  0.03). Furthermore, at 55% versus 63%, they
less often had a history of smoking (p  0.013). Except for
the difference in the incidence of the right coronary or
circumflex artery as the infarct-related artery, other baseline
and angiographic characteristics were comparable in both
p Value
Successful Aspiration
No Material
(n  283)
Material
(n  972) p Value
0.009 60 13 61 12 0.03
0.20 207 (73) 712 (73) 0.97
0.46 25 (9) 97 (10) 0.57
0.16 87 (31) 308 (32) 0.76
0.45 59 (21) 201 (21) 0.95
0.72 156 (55) 615 (63) 0.013
0.43 110 (39) 421 (43) 0.18
0.86 22 (8) 61 (6) 0.37
0.49 4 (1) 15 (2) 0.88
0.65 33 (12) 85 (9) 0.14
0.65 3.2 (2.2–4.6) 3.0 (2.1–4.4) 0.35
0.10 22 (8) 60 (6) 0.34
0.001 79 (28) 262 (27) 0.75
0.02 0.003
3 (1) 1 (0)
125 (44) 427 (44)
111 (39) 447 (46)
41 (15) 84 (9)
3 (1) 13 (1)
0.09 240 (85) 823 (85) 0.96
0.08 29 (10) 91 (9) 0.64
1.00 16 (6) 68 (7) 0.43
0.14 23 (8) 94 (10) 0.43
0.06 16 (6) 35 (4) 0.12
0.001 48 (17) 138 (14) 0.24
0.001 107 (42) 355 (40) 0.61
0.40 65 (25) 227 (26) 0.95
0.10 15.9 6.1 16.5 5.5 0.47
0.19 95 (38) 339 (37) 0.63
e; CABG coronary artery bypass grafting; Cx circumflex artery; LAD left anterior descending
coronary artery; SVG saphenous vein graft; TIMI Thrombolysis In Myocardial Infarctiontion
diseas
 rightgroups. Patient age over 60 years and the circumflex
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638coronary artery as infarct-related artery were independent
predictors for the absence of aspirate, at ORs of 1.37 (95%
CI: 1.04 to 1.80, p 0.025) and 1.84 (95% CI: 1.23 to 1.75,
p  0.003), respectively (Table 4).
Clinical outcome. Follow-up information on all-cause
ortality was available for all patients. Death rates at 1
ear were 6.2% in patients with failed TA, as compared to
Table 2. Univariable and Multivariable-Adjusted Logistic Regression Analys
the Likelihood of Failure of TA
Variable Present Absent
Age 60 yrs 85/673 (12.6) 59/726 (8.1)
Male 98/1,017 (9.6) 46/382 (12.0)
Diabetes mellitus 17/139 (12.2) 127/1,260 (10.1)
Hypertension 54/449 (12.0) 90/950 (9.5)
Hypercholesterolemia 34/294 (11.6) 110/1,105 (10.0)
History of smoking 91/862 (10.6) 53/537 (9.9)
Family history of CAD 66/597 (11.1) 78/802 (9.7)
Previous PCI 10/93 (10.8) 134/1,306 (10.3)
Previous CABG 3/22 (13.6) 141/1,236 (10.2)
Previous MI 15/133 (11.3) 129/1,266 (10.2)
Shock 4/86 (4.7) 140/1,313 (10.7)
Multivessel disease 58/399 (14.5) 86/1,000 (8.6)
IRA Cx 29/154 (18.8) 115/1,245 (9.2)
TIMI ﬂow grade 0 or 1 114/1,177 (9.7) 30/222 (13.5)
Bifurcation lesion 21/141 (14.9) 123/1,257 (9.8)
Ostial lesion 9/93 (9.7) 135/1,305 (10.3)
Distal lesion 19/136 (14.0) 125/1,263 (9.9)
Side branch 11/62 (17.7) 133/1,337 (9.9)
Calciﬁed lesion 48/234 (20.5) 96/1,164 (8.2)
Proximal tortuosity 91/553 (16.5) 43/724 (5.9)
45° lesion angle 39/331 (11.8) 95/946 (10.0)
ACC/AHA type C lesion 57/491 (11.6) 75/814 (9.2)
Values are number of patients with failed TA/total number of patients (%).
CI confidence interval; IRA infarct-related artery; OR odds ratio; TA thrombus aspiration
Table 3. Procedural Characteristics
Failed Aspiration
(n  144)
Successful
(n  1
Stenting 131 (93) 1,157
Direct stenting 13 (9) 376
Stent length 19.3 5.8 19.0
Stent diameter 3.4 0.6 3.5
GP IIb/IIIa inhibitor 65 (45) 499
Distal embolization 18 (13) 163
Post-procedural TIMI ﬂow grade 3 29 (14) 119
IABP inserted 7 (5) 106
Peak CK-MB 280 (144–495) 263 (127
Values are n (%), mean SD, or median (interquartile range).CK-MB creatine kinase-myocardial band; GP glycoprotein; IABP intra-aortic balloon pump; TIMI.4% in patients with successful TA (hazard ratio [HR]:
.98, 95% CI: 0.49 to 1.95, p  0.95). In the case of
uccessful crossing of the lesion, the mortality rate was 6.7%
n patients without aspirate, as compared to 6.3% in patients
ith aspirated material (HR: 1.08, 95% CI: 0.64 to 1.80,
 0.78). Figure 2 shows the Kaplan-Meier curves for
ll-cause mortality of the 3 different groups.
he Association of the Presence of a Clinical or Angiographic Feature and
Univariable Analysis Multivariable-Adjusted Analysis
95% CI p Value OR 95% CI p Value
1.15–2.32 0.006 1.27 0.86–1.88 0.23
0.54–1.13 0.19
0.73–2.13 0.43
0.91–1.87 0.14
0.79–1.78 0.42
0.75–1.54 0.68
0.82–1.63 0.42
0.53–2.08 0.88
0.41–4.74 0.61
0.64–1.98 0.69
0.15–1.13 0.09 0.47 0.17–1.34 0.16
1.27–2.58 0.001 1.35 0.91–2.00 0.13
1.46–3.57 0.001 1.67 0.95–2.95 0.077
0.45–1.06 0.087 0.64 0.40–1.03 0.064
0.98–2.66 0.061 1.97 1.15–3.37 0.013
0.46–1.89 0.84
0.88–2.48 0.14
0.99–3.84 0.052 1.03 0.45–2.33 0.95
1.96–4.20 0.001 2.70 1.77–4.13 0.001
2.13–4.57 0.001 2.88 1.92–4.31 0.001
0.81–1.78 0.37
0.90–1.86 0.17
abbreviations as in Table 1.
tion
p Value
Successful Aspiration
No Material
(n  283)
Material
(n  972) p Value
1.00 251 (92) 906 (93) 0.23
0.001 63 (22) 313 (32) 0.001
0.96 18.4 4.6 19.1 5.1 0.06
0.004 3.5 0.5 3.6 0.5 0.001
0.24 110 (39) 389 (40) 0.73
1.00 27 (10) 136 (14) 0.05
0.11 27 (10) 92 (10) 0.96
0.15 30 (11) 76 (8) 0.14
0.32 224 (95–384) 268 (136–462) 0.007is of t
OR
1.63
0.78
1.24
1.31
1.18
1.08
1.15
1.05
1.38
1.12
0.41
1.81
2.28
0.69
1.61
0.93
1.48
1.95
2.87
3.12
1.20
1.29Aspira
,255)
(93)
(30)
5.0
0.5
(40)
(13)
(10)
(8)
–445)Thrombolysis In Myocardial Infarction.
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639Discussion
Success of thrombus aspiration. The present analysis of a
large dataset of unselected acute STEMI patients dem-
onstrates that manual TA failed in a considerable number
of procedures where TA was attempted. Our data show
that the presence of a calcified lesion, marked tortuosity
of the infarct-related artery, and a bifurcation lesion are
independent predictors of failure of the aspiration cath-
eter to reach and/or cross through the infarct-related
lesion. In addition, when the segment could successfully
be engaged and crossed with the thrombectomy catheter,
no thrombotic material was obtained in a substantial part
of procedures. Our analyses show that restoration of
coronary flow was not influenced by failure of TA or
whether thrombotic aspirate was retrieved and, impor-
tantly, no difference in 1-year mortality was observed.
In the past years, several randomized controlled trials
examining the potential benefit of adjunctive TA during
PPCI have been published (9–11,13–15). Information on
the occurrence of failure of successful application of the
different TA devices is lacking in most of these reports. The
Table 4. Univariable and Multivariable-Adjusted Logistic Regression Ana
the Lack of Aspirate
Variable Present Absent O
Age 60 yrs 152/588 (25.9) 131/667 (19.6) 1
Male 207/919 (22.5) 76/336 (22.6) 1
Diabetes mellitus 25/122 (20.5) 258/1,133 (22.8) 0
Hypertension 87/395 (22.0) 296/860 (22.8) 0
Hypercholesterolemia 59/260 (22.7) 224/995 (22.5) 1
History of smoking 156/771 (20.2) 127/484 (26.2) 0
Family history of CAD 110/531 (20.7) 173/724 (23.9) 0
Previous PCI 22/83 (26.5) 261/1,172 (22.3) 1
Previous CABG 4/19 (21.1) 279/1,236 (22.6) 0
Previous MI 33/118 (28.0) 250/1,137 (22.0) 1
Shock 22/82 (26.8) 261/1,173 (22.3) 1
Multivessel disease 79/341 (23.2) 204/914 (22.3) 1
IRA Cx 42/125 (32.8) 242/1,130 (21.4) 1
TIMI ﬂow grade 0 or 1 240/1,063 (22.6) 43/192 (22.4) 1
Bifurcation lesion 29/120 (24.2) 253/1,134 (22.3) 1
Ostial lesion 16/84 (19.0) 266/1,170 (22.7) 0
Distal lesion 23/117 (19.7) 260/1,138 (22.8) 0
Side branch 16/51 (31.4) 267/1,204 (22.4) 1
Calciﬁed lesion 48/186 (25.8) 234/1,068 (21.9) 1
Proximal tortuosity 107/462 (23.2) 149/681 (21.9) 1
45° lesion angle 55/292 (22.3) 191/851 (22.4) 0
ACC/AHA type C lesion 95/434 (21.9) 153/734 (20.7) 1
Values are number of patients without aspirate/total number of patients with successful TA (%).
Abbreviations as in Tables 1 and 2.largest trial comparing the Rescue catheter with conven-tional PPCI did report failure to cross the lesion in 11%
of cases despite pre-dilation (9). The TAPAS (Thrombus
Aspiration During Percutaneous Coronary Intervention in
Acute Myocardial Infarction) trial is the largest trial com-
paring the adjunctive use of the Medtronic aspiration
catheter with conventional PPCI (13). In this study, pa-
tients with lesions that were judged by the operator to be too
tortuous or too small for delivery of the aspiration catheter
were crossed over to the conventional treatment group. No
details are available for the treatment success rates of the
actual patients in which TA was attempted. Likewise, the
authors of the EXPIRA (Thrombectomy With Export
Catheter in Infarct-Related Artery During Primary Per-
cutaneous Coronary Intervention) trial, which is a smaller
trial investigating the use of the Medtronic aspiration
catheter compared with conventional PPCI, did not
describe in what proportion TA had failed (14). The
recently published PREPARE (Proximal Embolic Pro-
tection in Acute MI and Resolution of ST-Elevation)
trial is the only randomized controlled trial in which the
Proxis system was investigated (15). In 6% of patients,
the system could not be satisfactorily positioned, al-
for the Association of Clinical and Angiographic Variables and
Univariable Analysis Multivariable-Adjusted Analysis
95% CI p Value OR 95% CI p Value
1.09–1.86 0.009 1.37 1.04–1.80 0.025
0.74–1.34 0.97
0.55–1.39 0.57
0.72–1.27 0.76
0.73–1.40 0.95
0.55–0.93 0.013 0.76 0.58–1.01 0.054
0.64–1.09 0.18
0.76–2.09 0.37
0.30–2.78 0.88
0.90–2.11 0.14
0.77–2.13 0.34
0.78–1.41 0.75
1.20–2.67 0.004 1.84 1.23–2.75 0.003
0.70–1.46 0.96
0.71–1.72 0.64
0.46–1.40 0.44
0.51–1.33 0.43
0.87–2.94 0.13
0.87–1.78 0.24
0.81–1.43 0.61
0.72–1.36 0.95
0.80–1.43 0.63lysis
R
.43
.00
.87
.96
.01
.71
.83
.26
.92
.38
.28
.05
.79
.01
.11
.80
.83
.60
.24
.08
.99
.07though only patients with lesions presumably suitable for
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640treatment with the device were included. At an incidence
of 10.3%, the proportion of failure observed in our analysis
is comparable to that described by Kaltoft et al. (9).
Predictors of failure of thrombus aspiration. In the current
study, predictors of failure of TA were generally lesion-
specific rather than patient-dependent. Previously, the pres-
ence of marked tortuosity and coronary calcification have
been identified to be predictors of failure of intravascular
ultrasound imaging, at a rate of 23% failed procedures
described in a prospective cohort of patients with stable or
unstable angina (16). The difference in flexibility of the
catheters used for intravascular ultrasound with those cur-
rently used for TA and the dissimilar patient characteristics
may explain the lower failure rate we observed. Additionally,
the presence of a type C lesion was not an independent
predictor of failure of TA. The American College of
Cardiology/American Heart Association lesion morphology
was originally introduced to provide a tool for estimation of
the difficulty of a procedure and its probability of angio-
graphic success (17). This concept of lesion morphology
classification is not well defined for STEMI patients pre-
senting with an acutely occluded vessel, which may explain
the lack of correlation with TA failure in our observation.
After successful passage of the aspiration catheter
through the lesion, no material could be identified in 27.3%
of the patients in our cohort. This proportion is comparable
with that reported in the TAPAS trial, in which no material
was obtained in 27.1% of the procedures where TA was
Figure 2. Kaplan-Meier Curves
Cumulative incidence of all-cause mortality in patients with successful
thrombus aspiration (TA) with aspirate, patients with failed TA, and patients
with successful TA without aspirate.performed. The potency of endogenous fibrinolysis, en-hanced by pharmacological therapy administered promptly
after diagnosis before arrival at the catheterization labora-
tory, probably is a major contributor to this finding (18).
The diversity in the morphology of the vulnerable plaque in
acute myocardial infarction implies the possibility of a
nonthrombotic lesion (19), whereas distal embolization
could have occurred before treatment, either spontaneously
or because of manipulation by the guidewire. Furthermore,
the aspiration capacity of the devices used at our institution
may not be sufficient to remove large thrombus load, as
opposed to mechanical thrombectomy (20). During the
study period, we did not use mechanical devices in the
absence of beneficiary evidence in literature.
Survival. Interestingly, we found that survival at 1 year was
not influenced by failure of the TA catheter to reach and/or
cross the infarct-related lesion or, in the case of successful
catheter passage, if thrombotic material could be retrieved.
In previous reported investigations, removal of thrombus
from the infarct-related artery reduced no-reflow by limit-
ing the embolization of thrombotic material and was asso-
ciated with improved TIMI flow and MBG, with an
inconsistent effect on clinical outcome (4–7). It proved to be
difficult to translate the benefit in surrogate endpoints in
better clinical outcome. The TAPAS trial was the first trial
to report better clinical outcome after routine manual TA
compared with conventional PPCI (21). The occurrence of
distal embolization, however, was not influenced by TA
(22). The deterioration in coronary perfusion, as seen fre-
quently in PPCI, is a complex condition related to multiple
factors as endothelial dysfunction, microvascular obstruc-
tion, and reperfusion injury (23). These are unlikely to be
affected simultaneously by TA alone. Thus, in the case of
prompt restoration of coronary flow after wiring the coro-
nary artery, the additional effect of TA on prognosis
probably is modest. However, TA commonly allows for
direct stenting, which was reported to be associated with
reduced microvascular injury (24). In the present analysis,
the final TIMI flow grade was not affected by failure of
TA, which could explain, to some extent, the lack of a
prognostic association of successful TA on 1-year mor-
tality (25). In addition, the prognosis of these unselected
acute STEMI patients may have been influenced by uniden-
tified confounders or comorbidities associated with worse out-
comes (26).
Study limitations. First, in our institution, TA is executed
on the judgment of the interventional cardiologist, which
could have resulted in selection bias. However, we studied
patients in whom TA was attempted, where the operator
considered the infarct-related lesion as suitable for TA.
Second, the available data on surrogate outcomes are lim-
ited. The effect of TA on MBG could not be determined
because the appropriate images to assess MBG were not
collected routinely as part of daily practice. In addition,
because patients were transferred to the referring hospitals
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641within hours after the procedure, infarct size could not be
determined accurately as information on serial serum mark-
ers or left ventricular function was not available. Still, peak
creatine kinase-myocardial band values were available in a
considerable proportion of patients and were comparable in
both groups. Furthermore, follow-up information was lim-
ited to vital status alone; therefore, a possible cardiac cause
of death could not be identified.
Conclusions
Our findings demonstrate that in a considerable proportion
of patients presenting with STEMI, the successful comple-
tion of TA during PPCI is limited either by the inability to
reach and/or cross the infarct-related lesion, or by the lack
of aspirate retrieved from the lesion. Marked proximal
tortuosity of the infarct-related artery, the presence of a
calcified lesion, and the presence of a bifurcation lesion are
independent predictors of unsuccessful catheter passage
through the lesion. Failure of TA limits the ability of direct
stenting but has no influence on restoration of coronary flow
as compared to successful TA. Age above 60 years and the
circumflex artery as infarct-related artery were indepen-
dently associated with the absence of aspirated material after
successful passage of the infarct-related lesion. In our
analysis of 1,399 unselected acute STEMI patients in whom
TA was attempted in adjunct to PPCI, compared with
successful TA, the failure to reach and/or cross the lesion
and the absence of aspirate did not affect 1-year all-cause
mortality.
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